Novavax Inc (NVAX.OQ)
NVAX.OQ on NASDAQ Stock Exchange Global Select Market
2.13USD
15 Feb 2019
2.13USD
15 Feb 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$2.13
$2.13
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
607
607
Avg. Vol
1,742,356
1,742,356
52-wk High
$2.75
$2.75
52-wk Low
$1.15
$1.15
About
Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates... (more)
Overall
| Beta: | 1.98 |
| Market Cap(Mil.): | $338.31 |
| Shares Outstanding(Mil.): | 294.18 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| NVAX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -0.77 | -- | -- |
| ROI: | -57.83 | 8.92 | 14.45 |
| ROE: | -829.23 | 10.08 | 15.96 |
Estimates